Beds In Rural Areas, Pricing Biggest Challenges To Ayushman Bharat Scheme
The biggest challenge to the Narendra Modi government's ambitious plan to provide healthcare to 10 crore families will be the availability of hospital beds in tier-II and tier-III cities and in rural areas, said Indu Bhushan, chief executive officer of Ayushman Bharat.
The prime minister announced the roll-out of a pilot project on Sept. 25 under the scheme, also known as the National Health Protection Mission, during his Independence Day address on Wednesday. Ten states and union territories have been selected for the pilot run.
The scheme is essentially a Rs 5-lakh cashless family floater insurance covering all members of the household for a year. Bhushan, in an interview with BloombergQuint, said the private sector will be incentivised to open more hospitals “in lagging areas”. The pilot project, he said, will initially involve only government-run hospitals.
We are targeting 50 crore people. If, on average, 2 percent of them need hospitalization, we would have 1 crore admissions. And if we say that each hospital can provide 200 bed days we would need 2 lakh beds.Indu Bhushan, CEO, Ayushman Bharat National Health Protection Mission
Bhushan admitted that a full roll-out—that will bring in approximately 50 crore Indians—in 40 days will be challenging. We have, from the hospitals that have come onboard, 60,000 beds, he said. He estimated that at least 2 lakh beds will be required if the scheme is to run at full capacity.
Pricing of health packages has been another pain-point, with the Indian Medical Association questioning the viability of providing healthcare at the proposed low costs. Bhushan said that this has been a “bone of contention” but assured that treatment rates under the scheme are “the median” and that states have the flexibility to change them.
We are hoping and expecting that we'll find a middle ground. This is just the beginning and we're putting a system in place for cost methodology.Indu Bhushan, CEO, Ayushman Bharat National Health Protection Mission
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
